Abnormal promoter DNA methylation in juvenile myelomonocytic leukemia is not caused by mutation in DNMT3A

Blood

Volumn 118, Issue 16, 2011, Pages 4490-4491

  Wlodarski, Marcin W ^a   Mötter, Jessica ^a   Gorr, Thomas A ^a,b   Olk Batz, Christiane ^a   Hasle, Henrik ^c   Dworzak, Michael ^d   Niemeyer, Charlotte M ^a   Flotho, Christian ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA METHYLTRANSFERASE 3A; MESSENGER RNA;

CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DNA METHYLATION; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; JUVENILE MYELOMONOCYTIC LEUKEMIA; LETTER; LEUKEMIA; LEUKEMIA CELL; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 80054831481     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-07-370684     Document Type: Letter

References (8)

1. Ley TJ, Ding L, Walter MJ, et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med. 2010;363(25):2424-2433.
2. Yan XJ, Xu J, Gu ZH, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet. 2011;43(4):309-315.
3. Thol F, Damm F, Ludeking A, et al. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. J Clin Oncol. 2011;29(21):2889-2896.
4. Olk-Batz C, Poetsch AR, Nöllke P, et al. Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia (JMML) with poor outcome. Blood. 2011;117(18):4871-4880.
5. Mizuno S, Chijiwa T, Okamura T, et al. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood. 2001;97(5):1172-1179. (Pubitemid 32183737)
6. Ho PA, Kutny MA, Alonzo TA, et al. Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2011;57(2):204-209.
7. Walter MJ, Ding L, Shen D, et al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia. 2011;25(7):1153-8.
8. Thol F, Heuser M, Damm F, Klusmann JH, Reinhardt K, Reinhardt D. DNMT3A mutations are rare in childhood acute myeloid leukemia. Haematologica. 2011;96(8):1238-1240.